Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Bertola

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Italian Journal of Pediatrics|November 17, 2018
Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must knowMirella Filocamo, Rosella Tomanin, Francesca Bertola, et al.
Genes|November 27, 2021
Identification of Novel Mutations by Targeted NGS Panel in Patients with HyperferritinemiaGiulia Ravasi, Sara Pelucchi, Francesca Bertola, et al.
Neurobiology of Aging|February 2, 2013
Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson's diseaseLaura Brighina, Chiara Riva, Francesca Bertola, et al.
Parkinsonism & Related Disorders|July 20, 2011
Association analysis of PARP1 polymorphisms with Parkinson's diseaseLaura Brighina, Chiara Riva, Francesca Bertola, et al.
American Journal of Human Genetics|July 25, 2023
A form of inherited hyperferritinemia associated with bi-allelic pathogenic variants of STAB1Edoardo Monfrini, Sara Pelucchi, Maija Hollmén, et al.
BMC Pulmonary Medicine|November 7, 2025
A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implicationsGiovanni Franco, Francesca Bertola, Filippo Aloisi, et al.
European Journal of Pediatrics|February 28, 2019
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter studyAlessandra Zanetti, Francesca D'Avanzo, Laura Rigon, et al.
Frontiers in Pharmacology|May 21, 2026
Pilot study on esketamine response in treatment-resistant depression: impact of pharmacogenetic, clinical, and demographic variablesMichaela Krivosova, Matteo Marcatili, Gessica Guerrera, et al.
Neurogenetics|April 9, 2024
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutationFederico Emanuele Pozzi, Vittoria Aprea, Ginevra Giovannelli, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2025
Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non-Small-Cell Lung Cancer: An Italian Multi-Institutional ExperienceIda Rapa, Francesca Bertola, Gaia Roversi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Italian Journal of Pediatrics|November 17, 2018
Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must knowMirella Filocamo, Rosella Tomanin, Francesca Bertola, et al.
Genes|November 27, 2021
Identification of Novel Mutations by Targeted NGS Panel in Patients with HyperferritinemiaGiulia Ravasi, Sara Pelucchi, Francesca Bertola, et al.
Neurobiology of Aging|February 2, 2013
Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson's diseaseLaura Brighina, Chiara Riva, Francesca Bertola, et al.
Parkinsonism & Related Disorders|July 20, 2011
Association analysis of PARP1 polymorphisms with Parkinson's diseaseLaura Brighina, Chiara Riva, Francesca Bertola, et al.
American Journal of Human Genetics|July 25, 2023
A form of inherited hyperferritinemia associated with bi-allelic pathogenic variants of STAB1Edoardo Monfrini, Sara Pelucchi, Maija Hollmén, et al.
BMC Pulmonary Medicine|November 7, 2025
A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implicationsGiovanni Franco, Francesca Bertola, Filippo Aloisi, et al.
European Journal of Pediatrics|February 28, 2019
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter studyAlessandra Zanetti, Francesca D'Avanzo, Laura Rigon, et al.
Frontiers in Pharmacology|May 21, 2026
Pilot study on esketamine response in treatment-resistant depression: impact of pharmacogenetic, clinical, and demographic variablesMichaela Krivosova, Matteo Marcatili, Gessica Guerrera, et al.
Neurogenetics|April 9, 2024
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutationFederico Emanuele Pozzi, Vittoria Aprea, Ginevra Giovannelli, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2025
Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non-Small-Cell Lung Cancer: An Italian Multi-Institutional ExperienceIda Rapa, Francesca Bertola, Gaia Roversi, et al.
Pageof 2